Overview

• Elizabeth Holmes is preparing to report to prison next week for her role in the Theranos blood-testing scam.
• Questions remain about her true intentions and whether her punishment fits her crime.
• Holmes raised nearly $1 billion from investors for technology that never worked and produced dangerously unreliable results.
• While her supporters claim she was unfairly targeted, her actions terrified whistleblowers and put patients at risk.
• The Theranos case highlights the danger of hyperbole and exaggeration in Silicon Valley's startup culture.